Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
Current Drug Targets|March 18, 2015
MicroRNAs and the Response of Prostate Cancer to Anti-Cancer DrugsMarzia Pennati, Marco Folini, Paolo Gandellini, et al.
Cell Calcium|November 12, 2020
Budgeting at the Ca2+ store: a PIP(2)eline to starve LSCs?Giovanni Monaco, Stefano Percio, Stephen B Ting
Cancer Gene Therapy|March 30, 2022
miR-550a-3p is a prognostic biomarker and exerts tumor-suppressive functions by targeting HSP90AA1 in diffuse malignant peritoneal mesotheliomaRihan El Bezawy, Stefano Percio, Chiara Maura Ciniselli, et al.
Pharmaceuticals (Basel, Switzerland)|November 25, 2023
Study of lncRNAs in Pediatric Neurological Diseases: Methods, Analysis of the State-of-Art and Possible Therapeutic ImplicationsCecilia Pandini, Federica Rey, Cristina Cereda, et al.
Cellular and Molecular Life Sciences : CMLS|March 14, 2016
Dissecting the role of microRNAs in prostate cancer metastasis: implications for the design of novel therapeutic approachesValentina Doldi, Marzia Pennati, Barbara Forte, et al.
Plos One|November 11, 2024
Post-transcriptional control drives Aurora kinase A expression in human cancersRoberta Cacioppo, Deniz Rad, Giulia Pagani, et al.
Current Topics in Medicinal Chemistry|December 27, 2011
RNA interference-mediated validation of survivin and Apollon/BRUCE as new therapeutic targets for cancer therapyMarzia Pennati, Enrico Millo, Paolo Gandellini, et al.
Current Medicinal Chemistry|February 16, 2013
MicroRNA-mediated control of prostate cancer metastasis: implications for the identification of novel biomarkers and therapeutic targetsNicola Fenderico, Anna Casamichele, Valentina Profumo, et al.
Current Pharmaceutical Design|July 1, 2014
MicroRNA-dependent regulation of telomere maintenance mechanisms: a field as much unexplored as potentially promisingFrancesca Santambrogio, Paolo Gandellini, Graziella Cimino-Reale, et al.
Pageof 8